Our portfolio

AI Biomics

Revolutionizing microbiome analysis, AIBiomics utilizes AI-driven image analysis to provide rapid, non-invasive stool sample diagnostics. They aim to offers quick and reliable microbial composition analysis using a smartphone camera. This innovative approach simplifies gut health monitoring, making it accessible and painless.

Industry: AI, Diagnostics, Digital Health, Software

Want to get in contact about AI Biomics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Innovating post-surgical care with advanced blood clot prevention devices.
Developing a bi-hormonal artificial pancreas for better diabetes management.
Discovering novel antibodies for cancer and infectious disease treatments.
Engineering antibodies to treat neurodegenerative and immune diseases.
Innovating post-surgical care with advanced blood clot prevention devices.
Developing a bi-hormonal artificial pancreas for better diabetes management.
Discovering novel antibodies for cancer and infectious disease treatments.
Engineering antibodies to treat neurodegenerative and immune diseases.